Quebec Network Réseau Québécoise de l’Amyotrophie Spinale Joins NMD4C as Community of Practice Sub-Group
We are thrilled to announce that the Réseau Québécoise de l’Amyotrophie Spinale (RQAS), a network uniting rehabilitation clinicians across Quebec to advance the care of people with Spinal Muscular Atrophy (SMA) since 2022, has officially become a sub-group Community of Practice of the Neuromuscular Disease Network of Canada (NMD4C).
This marks an exciting milestone for both the NMD4C and RQAS members, offering significant new opportunities and resources.
By welcoming the RQAS, the NMD4C gains:
- A well-established community of practice of 136+ members, including clinicians, researchers, and patient partners.
- Stronger French-Canadian representation, ensuring diverse perspectives in care, research, and policy.
- A proven model for clinician-driven collaboration, expanding best practices across neuromuscular diseases.
As a sub-group of the NMD4C, the RQAS will benefit from:
- Greater access to support for research, training, and initiatives to improve neuromuscular care.
- Enhanced organizational support, streamlining activities for greater efficiency.
- A broader national network, fostering collaboration, knowledge-sharing, and innovation.
Through incorporating RQAS into NMD4C, we will continue our efforts to unify, support, and advance neuromuscular care and research across Canada. We look forward to working together to drive innovation and improve outcomes for individuals with neuromuscular diseases. If you have any questions, contact Community of Practice Manager, Dr Maria Masnata at <>
Read next...
You Can Now Find NMD4C on Bluesky
We’re moving to Bluesky! The NMD4C will now share updates on Bluesky instead of X. Please consider following us at @nmd4c.ca to stay connected!
CIHR Funds Interdisciplinary Project to Study SBMA in Indigenous Peoples of the Prairie Provinces
The NMD4C is excited to share that network investigators have been awarded funding from the CIHR for an Interdisciplinary Spinal-bulbar muscular atrophy study in Indigenous peoples of the prairie provinces, addressing the community needs, and developing clinical knowledge and therapies.
NMD4C Presents the 2025 Early Career Award Recipients
We are excited to announce the recipients of the 2025 NMD4C Early Career Awards! This is the third year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.
Muscular Dystrophy Canada Launches Initiative to Improve Genetic Testing Access for Myotonic Dystrophy
Muscular Dystrophy Canada is thrilled to launch an innovative initiative designed to tackle the diagnostic hurdles experienced by individuals with myotonic dystrophy.
